Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Experimental therapeutics of neurodegenerative disorders: unmet needs.

Science (New York, N.Y.) - 6 Nov 1998

Shoulson I

Abstract excerpt

Viewpoint The experimental therapeutics of neurodegenerative disorders is in its infancy, but neuroprotective strategies are already being applied in healthy persons at high risk of developing disease as well as in patients with manifest illness. Knowledge of etiology and pathogenesis, improved design of clinical trials, the development of biological markers, the advent of genetic animal models, the enhanced...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Clinical Trials as Topic
Share to Drug Evaluation, Preclinical

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Hepatolenticular Degeneration

Share to Huntington Disease

Share to Neurodegenerative Diseases

Share to Parkinson Disease

Source

Identifiers

PMID: 9804537
DOI: 10.1126/science.282.5391.1072

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Experimental therapeutics of neurodegenerative disorders: unmet needs.PMID 9804537Read ↗

Promising Targets for the Treatment of Neurodegenerative DiseasesSemantic proximity Read ↗

Next-generation neurotherapeutics: nanotechnology, immunotherapy, and gene editing for neurodegenerative diseasesSemantic proximity Read ↗

Transgenic animal models of neurodegenerative diseases and their application to treatment development☆Semantic proximity Read ↗

Gene-based therapies for neurodegenerative diseasesSemantic proximity Read ↗

Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases.Semantic proximity Read ↗

Molecular mechanisms and biomarkers in neurodegenerative disorders: a comprehensive reviewSemantic proximity Read ↗

Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer’s and Parkinson’s DiseasesSemantic proximity Read ↗

Huntington disease: pathogenesis, biomarkers, and approaches to experimental therapeuticsSemantic proximity Read ↗

Disease stages and therapeutic hypotheses in two decades of neurodegenerative disease clinical trialsSemantic proximity Read ↗

Experimental models of Parkinson's disease: Challenges and OpportunitiesSemantic proximity Read ↗

The paradigm of Huntington’s disease: Therapeutic opportunities in neurodegenerationSemantic proximity Read ↗

A guide to senolytic intervention in neurodegenerative diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.